A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in ...

Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation human liver organoid microarray platform that could help predict which drugs ...

New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling researchers to drive impactful, scalable genetic researchWALTHAM, Mass.--(BUSINESS WIRE)- ...

JA Rosenfeld is an employee of Signature Genomic Laboratories, a subsidiary of PerkinElmer, Inc. The authors have no other relevant affiliations or financial involvement with any organization or ...

NEW YORK--(BUSINESS WIRE)--Nucleus Genomics, a next-generation consumer genetic testing and analysis company, has raised $14 million in a new funding round led by Alexis Ohanian's Seven Seven Six. The ...

- The United States Biomedical Advanced Research and Development Authority (BARDA) has announced Vaxxas will receive US$2 million (AU$3.2 million) as a Concept Stage Winner in its multi-stage $50 ...

Autism spectrum disorder (ASD) is a complex and heterogeneous neurodevelopmental condition that affects approximately 1–2% of the global population. It is characterised by challenges in social ...

Scott W. Stuart, MD, MS; Casey H. King, BA; G. Shashidar Pai, MD Such observations emphasize the importance of clarifying the origin of a genetic variation by studying the parents for comparison. The ...

(Dr. Talat Khan, Doctor-in-charge, Medical Genetics, Metropolis Healthcare Limited) Autism spectrum disorder (ASD) is a multifactorial neurodevelopmental disorder that affects behaviour and social ...